Literature DB >> 8708536

Expression of granulocyte-colony stimulating factor and its receptor is regulated during the development of the human placenta.

S McCracken1, J E Layton, S C Shorter, P M Starkey, D H Barlow, H J Mardon.   

Abstract

The development of the placenta is dependent upon the regulated proliferation, invasion and differentiation of trophoblast. Expression of cytokines at the feto-maternal interface suggests that these molecules may participate in placentation. The expression of granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor (G-CSFR) during the development of the human placenta was studied by immunohistochemistry using an anti-G-CSF monoclonal antibody (mAb) and two novel anti-G-CSFR mAbs. G-CSF was present in the stroma of fetal chorionic villi and maternal decidual tissues throughout pregnancy. G-CSFR was detected at high levels in fetal first and third, but not second trimester placental tissues. Staining for G-CSFR was undetectable in maternal decidual tissue from all gestational stages. In first trimester tissues, staining for placental G-CSFR was strongest in differentiated syncytiotrophoblast and invasive, extravillous cytotrophoblast, and weak staining was evident in undifferentiated cytotrophoblast. Immunohistochemical data suggesting temporal regulation of G-CSFR were corroborated by Western blotting and amplification by reverse transcription and PCR of G-CSFR mRNA. These data suggested that expression of G-CSFR in the human placenta is regulated both temporally and spatially, and that placental G-CSF is involved in paracrine regulation, and indicate a role for G-CSF and G-CSFR in trophoblast growth or function during placentation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8708536     DOI: 10.1677/joe.0.1490249

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

1.  The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Stanley M Berry; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2011-07-30       Impact factor: 1.901

2.  Granulocyte-Colony Stimulating Factor related pathways tested on an endometrial ex-vivo model.

Authors:  Mona Rahmati; Marie Petitbarat; Sylvie Dubanchet; Armand Bensussan; Gerard Chaouat; Nathalie Ledee
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

3.  Expression of granulocyte colony stimulating factor receptor in human colorectal cancer.

Authors:  X Yang; F Liu; Z Xu; C Chen; X Wu; G Li; J Li
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

4.  Maternal serum granulocyte colony-stimulating factor levels and spontaneous preterm birth.

Authors:  Brian W Whitcomb; Enrique F Schisterman; Xiaoping Luo; Nasser Chegini
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

Review 5.  Signaling pathways involved in MDSC regulation.

Authors:  Prashant Trikha; William E Carson
Journal:  Biochim Biophys Acta       Date:  2014-04-13

6.  The role of G-CSF in recurrent implantation failure: A randomized double blind placebo control trial.

Authors:  Fatemeh Davari-Tanha; Ensieh Shahrokh Tehraninejad; Mohadese Ghazi; Zahra Shahraki
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-12

7.  A preliminary study of placental umbilical cord whole blood transfusion in under resourced patients with malaria in the background of anaemia.

Authors:  Niranjan Bhattacharya
Journal:  Malar J       Date:  2006-03-23       Impact factor: 2.979

8.  Immunohistochemical Study on the Expression of G-CSF, G-CSFR, VEGF, VEGFR-1, Foxp3 in First Trimester Trophoblast of Recurrent Pregnancy Loss in Pregnancies Treated with G-CSF and Controls.

Authors:  Fabio Scarpellini; Francesca Gioia Klinger; Gabriele Rossi; Marco Sbracia
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.